Met Life Investment Management, LLC Shockwave Medical, Inc. Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

53 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$191.17 - $325.63 $4.16 Million - $7.08 Million	21,757 New	21,757 $7.08 Million
Q4 2023 Feb 14, 2024	SELL	$160.99 - $215.69 $44,433 - $59,530	-276 Reduced 1.22%	22,285 $4.25 Million
Q3 2023 May 09, 2024	SELL	$194.33 - $283.97 $3.41 Million - $4.98 Million	-17,546 Reduced 43.75%	22,561 $4.49 Million
Q3 2023 Apr 29, 2024	SELL	$194.33 - $283.97 $173,342 - $253,301	-892 Reduced 3.8%	22,561 $4.49 Million
Q3 2023 Nov 14, 2023	SELL	$194.33 - $283.97 $173,342 - $253,301	-892 Reduced 3.8%	22,561 $4.49 Million
Q2 2023 Apr 29, 2024	BUY	$223.05 - $302.68 $5.23 Million - $7.1 Million	23,453 New	23,453 $6.69 Million
Q2 2023 Aug 10, 2023	SELL	$223.05 - $302.68 $3.71 Million - $5.04 Million	-16,654 Reduced 41.52%	23,453 $6.69 Million
Q1 2023 May 09, 2024	BUY	$175.41 - $217.92 $7.04 Million - $8.74 Million	40,107 New	40,107 $8.7 Billion
Q1 2023 May 15, 2023	SELL	$175.41 - $217.92 $104,193 - $129,444	-594 Reduced 1.46%	40,107 $8.7 Million
Q4 2022 May 10, 2024	SELL	$204.38 - $296.82 $113,839 - $165,328	-557 Reduced 1.35%	40,701 $8.37 Million
Q4 2022 Jun 14, 2023	BUY	$204.38 - $296.82 $121,401 - $176,311	594 Added 1.48%	40,701 $8.37 Million
Q4 2022 Mar 22, 2023	SELL	$204.38 - $296.82 $113,839 - $165,328	-557 Reduced 1.35%	40,701 $8.37 Million
Q4 2022 Feb 15, 2023	SELL	$204.38 - $296.82 $113,839 - $165,328	-557 Reduced 1.35%	40,701 $8.37 Million
Q3 2022 May 10, 2024	BUY	$195.21 - $310.53 $48,802 - $77,632	250 Added 0.61%	41,258 $11.5 Million
Q3 2022 Jun 14, 2023	BUY	$195.21 - $310.53 $224,686 - $357,420	1,151 Added 2.87%	41,258 $11.5 Million
Q3 2022 Mar 22, 2023	BUY	$195.21 - $310.53 $48,802 - $77,632	250 Added 0.61%	41,258 $11.5 Million
Q3 2022 Nov 14, 2022	BUY	$195.21 - $310.53 $48,802 - $77,632	250 Added 0.61%	41,258 $11.5 Million
Q2 2022 May 10, 2024	BUY	$115.91 - $214.48 $2.66 Million - $4.92 Million	22,944 Added 127.02%	41,008 $7.84 Million
Q2 2022 Jun 20, 2023	BUY	$115.91 - $214.48 $104,434 - $193,246	901 Added 2.25%	41,008 $7.84 Million
Q2 2022 Mar 22, 2023	BUY	$115.91 - $214.48 $2.66 Million - $4.92 Million	22,944 Added 127.02%	41,008 $7.84 Million
Q2 2022 Aug 11, 2022	BUY	$115.91 - $214.48 $2.66 Million - $4.92 Million	22,944 Added 127.02%	41,008 $7.84 Million
Q1 2022 May 10, 2024	BUY	$127.96 - $207.36 $2.31 Million - $3.75 Million	18,064 New	18,064 $3.75 Million
Q1 2022 Jun 20, 2023	SELL	$127.96 - $207.36 $2.82 Million - $4.57 Million	-22,043 Reduced 54.96%	18,064 $3.75 Million
Q1 2022 Mar 22, 2023	BUY	$127.96 - $207.36 $819,327 - $1.33 Million	6,403 Added 54.91%	18,064 $3.75 Million
Q1 2022 May 12, 2022	BUY	$127.96 - $207.36 $819,327 - $1.33 Million	6,403 Added 54.91%	18,064 $3.75 Million
Q4 2021 Jun 21, 2023	SELL	$165.13 - $241.83 $4.7 Million - $6.88 Million	-28,446 Reduced 70.93%	11,661 $2.08 Million
Q3 2021 May 17, 2024	SELL	$163.99 - $235.57 $58,216 - $83,627	-355 Reduced 2.95%	11,661 $2.4 Million
Q3 2021 Jun 21, 2023	SELL	$163.99 - $235.57 $4.66 Million - $6.7 Million	-28,446 Reduced 70.93%	11,661 $2.4 Million
Q3 2021 Mar 22, 2023	SELL	$163.99 - $235.57 $58,216 - $83,627	-355 Reduced 2.95%	11,661 $2.4 Million
Q3 2021 Nov 15, 2021	SELL	$163.99 - $235.57 $58,216 - $83,627	-355 Reduced 2.95%	11,661 $2.4 Million
Q2 2021 May 17, 2024	BUY	$131.45 - $201.49 $124,877 - $191,415	950 Added 8.58%	12,016 $2.28 Million
Q2 2021 Jun 21, 2023	SELL	$131.45 - $201.49 $3.69 Million - $5.66 Million	-28,091 Reduced 70.04%	12,016 $2.28 Million
Q2 2021 Mar 22, 2023	BUY	$131.45 - $201.49 $124,877 - $191,415	950 Added 8.58%	12,016 $2.28 Million
Q2 2021 Aug 16, 2021	BUY	$131.45 - $201.49 $124,877 - $191,415	950 Added 8.58%	12,016 $2.28 Million
Q1 2021 May 17, 2024	SELL	$92.73 - $142.05 $991,376 - $1.52 Million	-10,691 Reduced 49.14%	11,066 $1.44 Million
Q1 2021 Jun 26, 2023	SELL	$92.73 - $142.05 $2.69 Million - $4.13 Million	-29,041 Reduced 72.41%	11,066 $1.44 Billion
Q1 2021 Mar 22, 2023	SELL	$92.73 - $142.05 $94,399 - $144,606	-1,018 Reduced 8.42%	11,066 $1.44 Million
Q1 2021 May 14, 2021	SELL	$92.73 - $142.05 $94,399 - $144,606	-1,018 Reduced 8.42%	11,066 $1.44 Million
Q4 2020 Jun 22, 2023	SELL	$67.44 - $103.72 $1.89 Million - $2.91 Million	-28,023 Reduced 69.87%	12,084 $1.25 Million
Q3 2020 May 24, 2024	BUY	$42.79 - $75.8 $32,049 - $56,774	749 Added 6.61%	12,084 $916 Million
Q3 2020 Jun 26, 2023	SELL	$42.79 - $75.8 $1.2 Million - $2.12 Million	-28,023 Reduced 69.87%	12,084 $915,000
Q3 2020 Mar 22, 2023	BUY	$42.79 - $75.8 $32,049 - $56,774	749 Added 6.61%	12,084 $915,000
Q3 2020 Nov 13, 2020	BUY	$42.79 - $75.8 $32,049 - $56,774	749 Added 6.61%	12,084 $916,000
Q2 2020 May 24, 2024	SELL	$27.25 - $47.53 $283,999 - $495,357	-10,422 Reduced 47.9%	11,335 $537 Million
Q2 2020 Jun 26, 2023	SELL	$27.25 - $47.53 $784,037 - $1.37 Million	-28,772 Reduced 71.74%	11,335 $536,000
Q1 2020 Jul 12, 2023	SELL	$23.16 - $47.74 $666,359 - $1.37 Million	-28,772 Reduced 71.74%	11,335 $376,000
Q4 2019 Jul 12, 2023	SELL	$29.4 - $44.98 $845,896 - $1.29 Million	-28,772 Reduced 71.74%	11,335 $497,000
Q4 2019 Mar 22, 2023	BUY	$29.4 - $44.98 $217,030 - $332,042	7,382 Added 186.74%	11,335 $497,000
Q4 2019 Feb 14, 2020	BUY	$29.4 - $44.98 $217,030 - $332,042	7,382 Added 186.74%	11,335 $498,000
Q3 2019 Jul 12, 2023	SELL	$29.71 - $55.23 $1.07 Million - $2 Million	-36,154 Reduced 90.14%	3,953 $118,000
Q3 2019 Mar 22, 2023	SELL	$29.71 - $55.23 $1.09 Million - $2.03 Million	-36,748 Reduced 90.29%	3,953 $118,000
Q3 2019 Nov 14, 2019	BUY	$29.71 - $55.23 $117,443 - $218,324	3,953 New	3,953 $118,000
Q2 2019 Jul 12, 2023	SELL	$29.73 - $66.02 $1.07 Million - $2.39 Million	-36,154 Reduced 90.14%	3,953 $226 Million

Others Institutions Holding SWAV

# of Institutions

Shares Held

321K

Call Options Held

1.9K

Put Options Held

View Full List

About Shockwave Medical, Inc.

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

More about SWAV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account